---
figid: PMC5393956__nihms811211f2
figtitle: mTORC1 and mTORC2 in cancer and the tumor microenvironment
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
pmcid: PMC5393956
filename: nihms811211f2.jpg
figlink: /pmc/articles/PMC5393956/figure/F2/
number: F2
caption: mTOR signaling is activated by a variety of environmental cues including
  growth factors, high cellular energy, and amino acids. Growth factors activate both
  mTORC1 and mTORC2, through binding of receptor tyrosine kinases (RTKs) or G-protein
  coupled receptors (GPCRs) and activation of PI3K or Ras-MAPK signaling cascades.
  PI3K phosphorylates PIP2 to increase the amount of PIP3 in the membrane, allowing
  co-localization of AKT, PDK1 and mTORC2. PDK1 phosphorylates AKT at T308, while
  mTORC2 phosphorylates AKT at S473 for complete activation. AKT in turn activates
  mTORC1 by inhibiting TSC2, a GAP for RHEB, an activator of mTORC1. AKT phosphorylation
  of PRAS40 promotes its dissociation from mTORC1 for full activation. ERK and RSK,
  both part of the Ras-MAPK signaling pathway, can also inhibit TSC2 to activate mTORC1
  or activate mTORC1 directly through phosphorylation of PRAS40. High ATP levels in
  the cell inhibit AMPK, an activator of TSC2, thereby increasing the activities of
  RHEB and mTORC1. Intra-lysosomal arginine and cytoplasmic leucine stimulate Rag-dependent
  localization of mTORC1 to the lysosome where RHEB can activate mTORC1. Cytoplasmic
  glutamine triggers lysosomal localization of mTORC1 through a Rag-independent mechanism.
  Downstream targets of mTORC1 include S6K1 and 4EBP1, while downstream targets of
  mTORC2 include AKT, PKC, and SGK. S6K1 inhibits PI3K, completing a negative feedback
  loop on AKT signaling.
papertitle: mTORC1 and mTORC2 in cancer and the tumor microenvironment.
reftext: Laura C. Kim, et al. Oncogene. 2017 Apr 20;36(16):2191-2201.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9664718
figid_alias: PMC5393956__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC5393956__F2
ndex: 35703053-ded0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5393956__nihms811211f2.html
  '@type': Dataset
  description: mTOR signaling is activated by a variety of environmental cues including
    growth factors, high cellular energy, and amino acids. Growth factors activate
    both mTORC1 and mTORC2, through binding of receptor tyrosine kinases (RTKs) or
    G-protein coupled receptors (GPCRs) and activation of PI3K or Ras-MAPK signaling
    cascades. PI3K phosphorylates PIP2 to increase the amount of PIP3 in the membrane,
    allowing co-localization of AKT, PDK1 and mTORC2. PDK1 phosphorylates AKT at T308,
    while mTORC2 phosphorylates AKT at S473 for complete activation. AKT in turn activates
    mTORC1 by inhibiting TSC2, a GAP for RHEB, an activator of mTORC1. AKT phosphorylation
    of PRAS40 promotes its dissociation from mTORC1 for full activation. ERK and RSK,
    both part of the Ras-MAPK signaling pathway, can also inhibit TSC2 to activate
    mTORC1 or activate mTORC1 directly through phosphorylation of PRAS40. High ATP
    levels in the cell inhibit AMPK, an activator of TSC2, thereby increasing the
    activities of RHEB and mTORC1. Intra-lysosomal arginine and cytoplasmic leucine
    stimulate Rag-dependent localization of mTORC1 to the lysosome where RHEB can
    activate mTORC1. Cytoplasmic glutamine triggers lysosomal localization of mTORC1
    through a Rag-independent mechanism. Downstream targets of mTORC1 include S6K1
    and 4EBP1, while downstream targets of mTORC2 include AKT, PKC, and SGK. S6K1
    inhibits PI3K, completing a negative feedback loop on AKT signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gpbar1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Pten
  - Zhx2
  - Pdk1
  - Pdpk1
  - Mdk
  - Tsc1
  - Tsc2
  - Akt1
  - Ephb2
  - Mapk1
  - Sgk1
  - Rps6ka1
  - Rheb
  - App
  - H2-Ab1
  - Rps6kb1
  - Eif4ebp1
  - IGBP1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PDK1
  - PDPK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - TSC1
  - CCL26
  - TSC2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - SGK1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - RHEB
  - RHEBP1
  - RPTOR
  - APP
  - SUCLA2
  - EIF4EBP1
  - Tas2r134
  - Rxfp2
  - Pik3cg
  - Prkaa2
  - Ephb1
  - Prkcg
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
